Open AccessLong-term Methylphenidate Monotherapy for Parkinson’s: Biochemistry Analysis and 17 Year Case Study
Author(s) -
Robert W Townsend
Publication year - 2022
Language(s) - English
DOI - 10.46889/jnor.2022.3301
Subject(s) - methylphenidate , levodopa , alertness , adverse effect , medicine , psychiatry , modafinil , psychology , attention deficit hyperactivity disorder , pediatrics , parkinson's disease , pharmacology , disease